// June 26, 2023
Complex generics: Are global regulators addressing the needs?
The development of generic versions of innovator medicines is a global public health need.
The development of generic versions of innovator medicines is a global public health need.
The issue of addressing potential nitrosamine impurities in medicines has been the focus at event
To help strengthen the pharmaceutical supply chain and guard against potential shortages that can
Another public health crisis looms in the wake of the COVID-19 pandemic.